Mature retinal ganglion cells (RGCs), like other CNS neurons, cannot regrow injured axons into a myelin-rich environment. If stimulated by macrophage-derived factors, however, RGCs can regenerate their axons for considerable distances through the distal optic nerve. Using this "sensitized background," we investigated the effects of either increasing the expression or suppressing the activity of the Nogo receptor (NgR). NgR mediates the growth-inhibiting effects of three myelin proteins, Nogo, OMgp (oligodendrocyte-myelin glycoprotein), and MAG (myelin-associated glycoprotein). Transfecting growth-sensitized RGCs with adeno-associated viruses expressing a dominant-negative form of NgR (NgR DN ) increased axon regeneration several-fold; however, when the growth program of RGCs was not activated, NgR DN expression had no beneficial effects. Overexpression of wild-type NgR blocked almost all regeneration from growthsensitized RGCs and caused axons proximal to the lesion site to retract. We conclude that gene therapy is an effective approach to enhancing axon regeneration in the CNS and that inactivation of NgR functioning greatly enhances axon regeneration provided the intrinsic growth program of neurons is activated.
Introduction
The inability of CNS neurons to regenerate damaged axons severely limits functional recovery after traumatic injury, stroke, or certain neurodegenerative diseases. Regenerative failure has been attributed in part to proteins associated with CNS myelin and the scar that forms at an injury site. Several myelin inhibitors of axon growth, including the C-terminal of NogoA (Nogo66) (Chen et al., 2000; GrandPre et al., 2000) , myelin-associated glycoprotein (MAG) (McKerracher et al., 1994; Mukhopadhyay et al., 1994) , and oligodendrocyte-myelin glycoprotein (OMgp) (Wang et al., 2002a) , exert their effects via the Nogo receptor (NgR) and p75 NTR or another co-receptor (Fournier et al., 2001; Domeniconi et al., 2002; Liu et al., 2002; Wang et al., 2002a,b) . In culture, ectopic NgR expression causes growth cones of embryonic chick retinal ganglion cells (RGCs) to collapse after contacting Nogo66 (Fournier et al., 2001 ) and inhibits cerebellar granule cells from extending neurites on MAG, OMgp, or myelin (Wang et al., 2002a,b) . Conversely, transfection with a dominant-negative form of NgR (NgR DN ) enables cerebellar granule cells in culture to overcome the inhibitory effects of myelin, Nogo66, OMgp, and MAG (Domeniconi et al., 2002; Wang et al., 2002a,b) . Antibodies to NogoA or a small peptide inhibitor of NgR increase corticospinal tract (CST) regeneration to some extent in rats (Schnell et al., 1994; Bregman et al., 1995; GrandPre et al., 2002; Sicotte et al., 2003) , whereas genetic deletion of the NogoA gene in mice results in either modest CST regeneration (Kim et al., 2003b; or none . These findings have raised the question of whether overcoming specific myelin inhibitors, or suppression of signaling through NgR, is sufficient to promote extensive CNS regeneration in vivo Woolf, 2003; Zheng et al., 2003) . The optic nerve is a classic model for understanding regenerative failure or success in the mature mammalian CNS (Aguayo et al., 1991; Ramon y Cajal, 1991) . Axons that are injured in the mature rat optic nerve cannot grow back into the myelin-rich environment distal to the injury site. In addition, if axonal damage occurs close to the eye, RGCs undergo apoptosis after several days (Berkelaar et al., 1994) . Several intraocular manipulations, including injuring the lens (Fischer et al., 2000 (Fischer et al., , 2001 Leon et al., 2000) , injecting the proinflammatory agent zymosan , or inserting a peripheral nerve fragment (Berry et al., 1996) , partially reverse this situation and allow many RGCs to survive injury and regenerate lengthy axons into the optic nerve; these effects appear to be mediated via macrophage-derived factors acting in concert with a carbohydrate that is constitutively present in the eye . The partial regeneration that occurs under these conditions provides a sensi-tized background on which to investigate the significance of NgR in CNS regeneration. This was done here by transfecting RGCs with adeno-associated viruses (AAVs) carrying a gene for either wild-type NgR or a dominant-negative NgR.
Materials and Methods
physiological saline, 5% serum, 2% BSA, and 0.1% Tween 20. After three rinses in TBS, sections were incubated with fluorescent-tagged secondary antibodies, i.e., AlexaFluor 488-conjugated goat antibody to rabbit IgG or AlexaFluor 594-conjugated goat antibody to mouse IgG (1:500; 2 hr; room temperature), rinsed, and covered.
Optic nerve and retinal cross sections. Two weeks after nerve surgery, animals were killed with an overdose of anesthesia and perfused with PBS followed by 4% paraformaldehyde in PBS. Optic nerves with retinas attached were dissected and prepared for longitudinal sectioning as described . Sections were stained to visualize either GAP-43 [primary antibody prepared in sheep (Benowitz et al., 1988) ; 1:1000, followed by a fluorescent-tagged donkey anti-sheep IgG] or GFP, as above. Retinal cross sections were stained to visualize either GFP or ␤III tubulin (as above) or NgR. The latter was visualized using a primary antibody made in goat to the N terminus of NgR (1:10; Santa Cruz Biotechnology), followed by a fluorescent secondary antibody to goat IgG made in donkey (1:500).
Axon regeneration: quantitation. Regeneration was quantified as described (Leon et al., 2000; Yin et al., 2003) . In four longitudinal sections per case, under 400ϫ magnification, we counted the number of GAP-43-positive axons extending Ն500 m and Ն1 mm from the injury site and divided these numbers by the cross-sectional width of the nerve at the point where axons were counted. The number of axons per unit width of optic nerve was averaged across the four sections and used to calculate the total number of axons regenerating in the nerve (Leon et al., 2000; . The significance of intergroup differences was evaluated by Student's t tests.
Cell survival. Cross sections through the center of the retina were double-stained with antibodies to GFP and ␤III tubulin as described above. The numbers of ␤III tubulin-positive cells per section were counted in four to six sections per case, averaged for each case, and then averaged across all similarly treated animals to obtain group means and SEs.
Results
To investigate the role of NgR in vivo, we injected mature rats intravitreally with AAV (serotype 2) carrying a plasmid expressing either the wild-type Nogo receptor (NgR WT ) (Fournier et al., 2001) or a truncated, dominant-negative variant of NgR (Domeniconi et al., 2002; Wang et al., 2002a ) from a CMV promoter, along with enhanced GFP from an internal ribosome entry site (AAV-NgR WT -IGFP and AAV-NgR DN -IGFP, respectively). Controls were transfected with viruses expressing GFP alone (AAV-GFP). When examined 3 weeks later, the GFP reporter was detected in Ͼ75% of all RGCs ( Fig. 1 A-C) , in agreement with previous studies using a similar virus (Cheng et al., 2002; Martin et al., 2002) . GFP-labeled cells were localized almost exclusively within the ganglion cell layer (Fig. 1 D) in cells that are immunopositive for ␤III tubulin (Fig. 1 E, F ) . Within the retina, this tubulin isoform is expressed only in RGCs Yin et al., 2003) , which we verified by showing a complete overlap of ␤III tubulin immunostaining with Fluorogold labeling in RGCs after injecting the latter into the superior colliculus (data not shown). The specificity of transfection to RGCs presumably reflects a combination of the neural selectivity of AAV2 (Bartlett et al., 1998) and the ready access of intravitreal viral particles to RGC axons and somata.
NgR immunostaining was modest or weak in controls transfected with AAV-GFP ( Regeneration was investigated 2 weeks after optic nerve injury; previous work has shown that damaged axons have begun to grow back into the distal optic nerve by this time, provided macrophages have been activated intravitreally (Leon et al., 2000) . Regenerating axons are readily distinguished by staining with antibodies to GAP-43. GAP-43 is normally undetectable in the mature optic nerve but is strongly upregulated in RGC axons undergoing regeneration (Schaden et al., 1994; Berry et al., 1996; Leon et al., 2000) . The origin of the GAP-43-positive axons in RGCs has been shown previously by anterograde labeling and double immunostaining (Leon et al., 2000) . Controls with lens injury transfected with AAV-GFP (n ϭ 8) showed a moderate amount of regeneration distal to the injury site (Fig. 3A) , comparable with that reported in similarly treated animals without viral transfections (Fig. 4 A) (Leon et al., 2000) .
Two weeks after nerve crush and lens injury, animals overexpressing NgR WT showed 76% fewer axons regenerating Ն0.5 mm from the injury site than controls (Figs. 3B, 4A) (n ϭ 9; p Ͻ 0.01), and 96% fewer axons extending Ն1 mm ( p Ͻ 0.01). Many NgR WT -containing axons retracted from the lesion site toward the optic nerve head (Fig. 5 B, D) , reflecting the sensitivity of these † † p Ͻ 0.01, decrease relative to GFP-transfected controls; **p Ͻ 0.01, increase relative to GFP-transfected controls.
axons to myelin; this phenomenon was never observed in animals expressing GFP alone (Fig. 5 A, C) or NgR DN (data not shown). In striking contrast, expression of NgR DN greatly enhanced the number of axons regenerating into the optic nerve (Fig. 3C) . Two weeks after nerve crush and lens injury, animals expressing NgR DN (n ϭ 5) extended approximately 3 times more axons Ն1 mm beyond the injury site than growth-sensitized controls expressing GFP alone, and 75 times more axons than growthsensitized cases expressing NR WT (Fig. 4 A) . In general, although GFP could be visualized in many axons proximal to the injury site, fewer than half of the axons that extended beyond this point exhibited GFP immunofluorescence, presumably because of decreasing concentrations of the cytoplasmic reporter protein far from RGC somata; however, the longest regenerating axons frequently exhibited GFP staining (Fig. 3 E, F ) , which suggests that they may have arisen from RGCs that express high levels of NgR DN . This colocalization further confirms the origin of GAP-43-immunopositive axons in RGCs. Two weeks after nerve crush and lens injury, the longest axons in NgR DN -expressing cases extended ϳ3 mm from the injury site.
On average, the number of fibers that grew Ն0.5 mm distal to the injury site in growth-activated cases expressing NgR DN represents growth from ϳ1% of all RGCs. This number is likely to increase with time, as has been observed after macrophage activation alone (Leon et al., 2000) . Several factors, however, limit the amount of regeneration that can ultimately occur under these experimental conditions, including the rapid decline of the macrophage response to lens injury and hence the availability of appropriate trophic factors (Leon et al., 2000) ; the continued death of RGCs (Fischer et al., 2000; Leon et al., 2000) and the likelihood that many of the surviving ones are in a metabolically compromised state; diminished transgene expression shortly after optic nerve surgery (Cheng et al., 2002) ; and the strong inhibitory effects of the glial scar (McKeon et al., 1995) , which is apparent in comparing the number of GAP-43-positive axons proximal versus distal to the injury site (Leon et al., 2000) . Further research will be required to determine whether overcoming these problems will enable growth-activated, NgR DNexpressing RGCs to extend axons back to their central targets.
In the absence of lens injury, NgR DN expression did not enable RGCs to regenerate their axons into the optic nerve (Fig. 3D) . Quantitatively, no axons were counted Ն0.5 mm distal to the injury site in any animal without lens injury, regardless of which transgene was expressed (data not shown).
To investigate whether the effects of the three transgenes on axon regeneration might reflect differences in cell survival, we counted TUJ1-positive cells in retinal cross sections 2 weeks after nerve crush and lens injury. Transgene expression had no measurable effect on cell survival (Fig. 4B) .
To investigate whether altering NgR levels or function might affect the intrinsic ability of RGCs to extend axons, we investigated outgrowth on a more permissive substrate. As before, we transfected RGCs in vivo with either AAV-NgR WT -IGFP or AAV-NgR DN -IGFP and then performed optic nerve surgery combined with lens injury or sham intraocular surgery 3 weeks later.After 4 d, a time at which axotomized RGCs stimulated bymacrophage-derived factors go into a growth state (Fischer et al., 2000) , we explanted wedges of † † † p Ͻ 0.001, decrease relative to controls; ***p Ͻ 0.001, increase relative to controls. Scale bar, 100 m.
retinas onto a PLL substrate. Little outgrowth was seen in explants not exposed to growth factors in vivo (i.e., no lens injury) (Fig. 6 A) regardless of transgene expression (Fig. 6 F) . It should be noted that axotomized RGCs do not show signs of apoptosis at this time point (Berkelaar et al., 1994) . Retinas primed to grow as a result of lens injury in vivo showed strong outgrowth regardless of which transgene was expressed (Fig. 6 B-F ) . Figure 6 B-D illustrates strong outgrowth from RGCs expressing NgR WT , whereas Figure 6 E illustrates outgrowth from a growth-activated retina expressing NgR DN . As expected, the effects of transgene expression became apparent when explants were plated on a substrate containing myelin (Fig. 6G) . NgR WT overexpression decreased the percentage of axons growing Ն0.5 mm on a mixed myelin-laminin substrate by ϳ50% relative to controls, whereas expression of NgR DN doubled the percentage of long axons ( p Ͻ 0.001 in both cases).
Discussion
The results of this study show that NgR plays a major role in limiting axon regeneration in the mature optic nerve; however, extensive regeneration requires that, in addition to suppressing NgR activity, the intrinsic growth state of neurons must be activated. Our results show further that AAV-mediated transfection provides a highly effective means of altering either the levels or functioning of gene products important for axon regeneration in CNS neurons.
The critical role of NgR for optic nerve regeneration is evident from the dramatic enhancement of axon growth that occurs when growth-sensitized RGCs express a dominant-negative form of NgR, and conversely, from the near-complete failure of growth-sensitized RGCs to regenerate their axons when overexpressing wild-type NgR. In mature mice, a null mutation of the NgR gene does not enhance regeneration of the CST but does increase sprouting of essential descending serotonergic projections after spinal cord injury (Kim et al., 2003a) . On the basis of the present study, we would propose that the contrasting results seen in CST versus serotonergic axons after NgR deletion may reflect intrinsic differences in the growth state of cortical pyramidal cells versus raphe neurons, and that activation of the former with appropriate trophic factors could lead to better CST regeneration.
Alterations of NgR functioning (or levels) and activation of the axonal growth program appear to be mostly independent of one another. As shown in the explant studies, altering NgR functioning or levels did not affect the ability of neurons to extend axons on a permissive substrate, and activating the intrinsic growth state of RGCs still left axons partially responsive to the effects of myelin proteins. Activation of the growth program of RGCs by macrophage-derived factors greatly increases the expression of GAP-43 and other regenerationassociated genes, but does not appreciably alter mRNA levels for NgR or p75, a NgR co-receptor (D. Fischer and L. Benowitz, unpublished gene profiling results). Inhibition of RhoA, an essential downstream mediator of NgR functioning, allows for limited axon regeneration when an ADP ribosyl transferase is delivered at the site of optic nerve injury in the absence of intravitreal macrophage activation (Lehmann et al., 1999) . The presence of intense GAP-43 immunoreactivity in axons extending beyond the injury site provides strong evidence that these are regenerating rather than spared axons, because the latter do not show detectable levels of GAP-43 (Schaden et al., 1994; Berry et al., 1996; Leon et al., 2000) . The fact that the GAP-43-positive axons do not extend the length of the optic nerve further suggests that they are regenerating, because spared axons would extend the full length of the nerve.
AAV-mediated transfection of growth-sensitized RGCs represents a general approach for investigating the role of various gene products in axon regeneration. By this method, one can readily obtain precise temporal and spatial control of gene expression without the expense, time delays, and possible developmental problems inherent in transgenic technology. The specificity and efficiency of RGC transfection by AAV found here has also been demonstrated in other studies (Cheng et al., 2002; Martin et al., 2002) .
The clinical implications of this work are clear: extensive axon regeneration may not be attainable in the mature CNS by overcoming inhibitory signals alone but may require that the intrinsic growth state of neurons be activated at the same time (Schnell et al., 1994; Cheng et al., 1996; Guest et al., 1997) . Even when these two approaches are combined, additional barriers to growth remain to be breached, e.g., chondroitin sulfate proteoglycans and other proteins associated with the glial scar (McKeon et al., 1995; Moon et al., 2001) , amino-NogoA (Spillmann et al., 1998; Fournier et al., 2001; Niederost et al., 2002; Oertle et al., 2003) , diffusible axon-repellant signals (Oster et al., 2003) , and a possible developmental loss of appropriate guidance cues. Nonetheless, the strong regeneration that results from simultaneously overcoming inhibitory signaling and activating the growth program of neurons lends encouragement to the possibility that clinically significant axon regeneration can be achieved in the injured human CNS.
